Jenburkt Pharmaceuticals Ltd

NSE: BSE: 524731

₹1045

(0.09%)

Fri, 08 May 2026, 04:46 pm

MTF 5xInvest in Jenburkt Pharmaceuticals Ltd with 5x Leverage Buy with MTF

Market Cap4.62B

PE Ratio14.22

Dividend1.72

Health Technology

Pharmaceuticals: Major

24.5K

Jenburkt Pharmaceuticals News

Jenburkt Pharma Files FY26 Audited Results Under Reg 33

Jenburkt Pharmaceuticals published standalone audited financial results for Q4 and FY26 ended March 31, 2026, approved by the Board on May 5, 2026.

06 May 2026

companies

Jenburkt Pharmaceuticals confirms 'not a large corporate' status for FY26

Jenburkt Pharmaceuticals Limited disclosed to BSE that it maintains 'not a large corporate' status for financial year ended March 31, 2026, as per SEBI regulatory requirements.

14 Apr 2026

companies

Jenburkt Pharma Files Q4 FY26 Compliance Certificate

Jenburkt Pharmaceuticals submits mandatory quarterly certificate to BSE confirming compliance with SEBI dematerialization regulations for Q4 FY26 period ended March 31, 2026.

07 Apr 2026

companies

Jenburkt Pharmaceuticals Q3FY26 Results

Jenburkt Pharmaceuticals reported Q3FY26 revenue of Rs 4302.39 lacs and net profit of Rs 593.14 lacs. Nine-month revenue reached Rs 12410.83 lacs with profit of Rs 2388.66 lacs.

03 Feb 2026

co actions results

Jenburkt Pharmaceuticals Reports 10.5% Revenue Growth in Q2 FY2026

Jenburkt Pharmaceuticals Limited announced its quarterly results for the quarter ended September 30, 2025. Revenue from operations increased to Rs 4,555.7 lacs compared to Rs 4,121.5 lacs in the same quarter last year, representing a 10.5% growth. Profit after tax rose to Rs 1,133.2 lacs from Rs 1,018.2 lacs year-over-year. For the half-year period, total revenue reached Rs 8,108.4 lacs versus Rs 7,375.16 lacs in the previous year. The company operates exclusively in the pharmaceuticals business segment. The Board meeting was held on October 28, 2025, where the Audit Committee recommended and the Board approved these unaudited financial results.

28 Oct 2025

earnings

Showing 1–5 of 14

Rows per page:

Market Current News

S&P 500 Rises 8.23 Points at Market Open to 7,373.35

S&P 500 opens up 8.23 points, or 0.11%, at 7,373.35, building on the prior session's unofficial close of 7,367.67, which was up 108.45 points or 1.49%.

07 May 2026

global

Dow Jones Rises 181.75 Points at Market Open

The Dow Jones Industrial Average climbed 181.75 points, or 0.36%, to 50,092.34 shortly after the market opened.

07 May 2026

global

Ceigall India Limited

Ceigall India IPO Proceeds Fully Utilised: Q4FY26 Report

ICRA Limited's monitoring agency report for Q4FY26 confirms Ceigall India's IPO proceeds of INR 684.252 crore have been fully utilised with no material deviation from offer document objects.

07 May 2026

ipo

Pajson Agro India Limited

Pajson Agro IPO Monitoring Agency Report for Q4 FY26

CARE Ratings submits Monitoring Agency Report for Pajson Agro's IPO proceeds for Q4 FY26, flagging GCP allocation of ₹10.43 crore exceeding the ₹10 crore cap and a ₹13.22 crore capex shortfall.

07 May 2026

ipo

Pajson Agro India Limited

Pajson Agro Reports IPO Fund Use Deviation for H1 FY26

Pajson Agro India Limited reports a ₹1.96 crore reallocation from issue expenses to General Corporate Purposes in its IPO fund utilisation statement for the half year ended March 31, 2026.

07 May 2026

ipo

Showing 1–5 of 93472

Rows per page:

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800